CYP2D6 polymorphism in a Mexican American population

Clinical Pharmacology and Therapeutics

Volumn 70, Issue 6, 2001, Pages 552-560

  Mendoza, Ricardo ^b   Wan, Yu Jui Yvonne ^b   Poland, Russell E ^b   Smith, Michael ^b   Zheng, Yanping ^b   Berman, Nancy ^b   Lin, Keh Ming ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; DEXTROMETHORPHAN; DEXTRORPHAN;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLELES; ANTITUSSIVE AGENTS; CYTOCHROME P-450 CYP2D6; DEXTROMETHORPHAN; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MEXICAN AMERICANS; MIDDLE AGED; MOLECULAR WEIGHT; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0035651785     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2001.120675     Document Type: Article

References (42)

1. Localization of the CYP2D6 gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridization, and linkage analysis
2. Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6
3. Psychopharmacotherapy in the context of culture and ethnicity
4. Pharmacogenetics: The slow, the rapid, and the ultrarapid
5. Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data
6. Genetic polymorphism of drug metabolising enzymes in African populations: Implications for the use of neuroleptics and antidepressants
7. Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians
8. The oxidative metabolism of sparteine in the Cuna Amerindians of Panama: Absence of evidence for deficient metabolizers
9. A preliminary note on the transient polymorphic oxidation of sparteine in the Ngawbé Guaymí Amerindians: A case of genetic divergence with tentative phylogenetic time frame for the pathway
10. Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: Role of selection versus drift in world populations
11. Molecular heterogeneity at the CYP2D6 gene locus in Nicaraguans: Impact of gene-flow from Europe
12. Reconstruction of human evolution: Bringing together genetic, archaelogical and linguistic data
13. Virologic and genetic studies relate Amerind origins to the indigenous people of the Mongolia/Manchuria southeastern Siberia region
14. Drug metabolizing capacity in Mexican Americans
15. Ethnicity, culture, and psychopharmacology
16. Polymorphic dextromethorphan metabolism: Co-segregation of oxidative O-demethylation with debrisoquin hydroxylation
17. Simultaneous determination of dextromethorphan and three metabolites in plasma and urine using high-performance liquid chromatography with application to their disposition in man
18. Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes
19. Effective amplification of long targets from cloned inserts and human genomic DNA
20. DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): Evidence for two major allozymes in extensive metabolisers
21. Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes
22. The human CYP2D locus associated with a common genetic defect in drug oxidation: A G1934 a base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3′ splice recognition site
23. Detection of the poor metabolizer associated CYP2D6(D) gene deletion by long-PCR technology
24. Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: Polymorphism in RFLP and DNA sequence of CYP2D6
25. A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: Association with diminished debrisoquine hydroxylase activity
26. Genetic basis for differences in debrisoquin polymorphism between Spanish and other white populations
27. Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences
28. High frequency of CYP2D6 poor and "intermediate" metabolizers in black populations: A review and preliminary data
29. Analysis of the CYP2D6 gene polymorphism and enzyme activity in African Americans in Southern California
30. HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies
31. Origins of U.S. Hispanics: Implications for diabetes
32. Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population
33. Antidepressant agents: A cross-cultural study
34. Pharmacotherapy of Hispanic depressed patients: Clinical observations
35. Ethnic psychopharmacology: The Hispanic and native American perspective
36. Evolutionary relationships between black South American and African populations
37. Distribution of HLA and haploytpes of Colombian and Jamaican black populations
38. Mitochondrial DNA polymorphisms in Carib people of Belize
39. Major histocompatibility complex class II alleles and haplotypes and blood groups of four Amerindian tribes of northern Colombia
40. Neuroleptic dosing in Asian and Hispanic outpatients with schizophrenia
41. Nortriptyline kinetics in Hispanic and anglo subjects